PLSE - Pulse Biosciences, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue--
Cost of Revenue--
Gross Profit--
Operating Expenses
Research Development5,9882,578
Selling General and Administrative2,9331,224
Non Recurring--
Total Operating Expenses--
Operating Income or Loss-9,586-4,468
Income from Continuing Operations
Total Other Income/Expenses Net6868
Earnings Before Interest and Taxes-9,518-4,468
Interest Expense--
Income Before Tax-9,518-4,468
Income Tax Expense--1,657
Minority Interest--
Net Income From Continuing Ops-9,518-2,811
Non-recurring Events
Discontinued Operations--
Extraordinary Items--
Effect Of Accounting Changes--
Other Items--
Net Income
Net Income-9,518-2,811
Preferred Stock And Other Adjustments--
Net Income Applicable To Common Shares-9,518-2,811